Don't miss Learning Studios and Satellite Symposia
Learn about the latest advances in stroke practices, services and technologies. Learning Studios are located in the Science & Technology Hall.
The Science & Technology Hall is open 9 a.m.-5 p.m. in the North Building, Lower Level, Hall 4.
Learning Studios
LS.02 | The Practical Use of AI in Building a Stroke Program
12:45-1:15 p.m. | Wednesday, Feb. 7 | Learning Studio I
Supporter: Rapid AI
LS.03 | Let’s Talk Data: Power of Registries
12:45-1:15 p.m. | Wednesday, Feb. 7 | Learning Studio II
Supporter: Medtronic Neuro
LS.04 | Precision in Practice: Accelerating Time to Treatment With Proven and Scalable AI Solutions
1:30-2 p.m. | Wednesday, Feb. 7 | Learning Studio I
Supporter: Viz.ai
LS.05 | Left Atrial Appendage Closure and the Heart-Brain Connection
1:30-2 p.m. | Wednesday, Feb. 7 | Learning Studio II
Supporter: Boston Scientific
LS.06 | Mobile Stroke Units: Past, Present and Future
2:15-2:45 p.m. | Wednesday, Feb. 7 | Learning Studio I
Supporter: Samsung NeuroLogica
LS.07 | Strengthening the Neurology and Cardiology Connection to Improve Stroke Care
9:15-9:45 a.m. | Thursday, Feb. 8 | Learning Studio I
Supporter: Medtronic
LS.08 | Powering the Extraordinary: Expanding Endovascular Thrombectomy in Emerging Countries
10-10:30 a.m. | Thursday, Feb. 8 | Learning Studio I
Supporter: Medtronic
LS.09 | (ANDEXXA) Management of FXa Inhibitor-Related Acute Major Bleeding
12:45-1:15 p.m. | Thursday, Feb. 8 | Learning Studio I
Supporter: AstraZeneca
LS.10 | Closing the Gap: A Review of Best Practices to Address Racial Disparities in Stroke Care
12:45-1:15 p.m. | Thursday, Feb. 8 | Learning Studio II
Supporter: Cerenovus
LS.11 | Navigating the Evidence Landscape: Recent Developments in AF and Stroke
1:30-2 p.m. | Thursday, Feb. 8 | Learning Studio I
Supporter: Medtronic
LS.13 | From Burnout to Nirvana: AI Documentation to Streamline Stroke Care
2:15-2:45 p.m. | Thursday, Feb. 8 | Learning Studio I
Supporter: Sevaro Health, Inc
LS.12 | Third Annual NIH Innovation Showcase
3:30-5 p.m. | Thursday, Feb. 8 | Learning Studio I
Supporter: NHLBI & NINDS Showcase
NOTE: These events are not part of the official International Stroke Conference 2024 as planned by the International Stroke Conference Program Committee.
Stroke Central programming
Bernard J. Tyson Reception
9:15-9:45 a.m. | Wednesday, Feb. 7 | Learning Studio II
Getting to Know the Stroke Council Scientific Statements and Stroke Guidelines
2:15-3 p.m. | Wednesday, Feb. 7 | Learning Studio II
Stroke Cases Requiring Neurocritical Care
3:30-4:30 p.m. | Wednesday, Feb. 7 | Learning Studio II
Approaches to Research: Success for the Early Career Researcher
9:15-9:50 a.m. | Thursday, Feb. 8 | Learning Studio II
Practical Approaches to Research Success: Advice on How to Get Started
10-10:45 a.m. | Thursday, Feb. 8 | Learning Studio II
2024 Update on Advancing the Study of Stroke in Women: PROWESS
2-3 p.m. | Thursday, Feb. 8 | Learning Studio II
Unspoken Bias: The Influence of Language and Culture on Stroke Care and Research
3:30-4:30 p.m. | Thursday, Feb. 8 | Learning Studio II
Satellite Symposia
Stroke Management of the Future? The Potential Role of Factor XI/XIa Inhibitors in Secondary Stroke Prevention
6-7:30 p.m. | Tuesday, Feb. 6
Hyatt Regency Phoenix Phoenix Ballroom, Second Floor
Sponsor: Duke Heart and Total CME
Sponsee: Bayer
Join experts to explore how factor XI/XIa inhibitors may transform secondary stroke prevention in patients with acute ischemic strokes and transient ischemic attack risk factors. This data-rich symposium reviews currently available therapeutics and how they affect the coagulation cascade, increasing the potential for serious bleeds. Experts outline new and emerging anticoagulation pharmacotherapy that may mitigate bleeding risks. Through interactive presentations, attendees gain a deep understanding of the rapidly evolving stroke prevention landscape, preparing them to implement the latest approaches, improve clinical practice and boost patient outcomes.
Optimizing ICH Care by Leveraging AC Reversal, AI and Care Bundling
6-7:30 p.m. | Wednesday, Feb. 7
Hyatt Regency Phoenix Phoenix Ballroom, Second Floor
Sponsor: AstraZeneca
Sponsor: Total CME & EMCREG- International
Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise and ultimately improve patient outcomes.
